<3033BFF8C0FA2DC3D6BFB5B9CE2E687770>

Similar documents
10-1(조사보고서).PDF

<30332EBFF8C0FA2DC3D6BFB5B9CE2E687770>

<30322EBAB8C1B6BBFDBDC4BCFA20C7F6C8B22DC3D6BFB5B9CE2E687770>

부속

00약제부봄호c03逞풚

달생산이 초산모 분만시간에 미치는 영향 Ⅰ. 서 론 Ⅱ. 연구대상 및 방법 達 은 23) 의 丹 溪 에 최초로 기 재된 처방으로, 에 복용하면 한 다하여 난산의 예방과 및, 등에 널리 활용되어 왔다. 達 은 이 毒 하고 는 甘 苦 하여 氣, 氣 寬,, 結 의 효능이 있

1..

歯 PDF

°Ç°�°úÁúº´6-2È£

YI Ggodme : The Lives and Diseases of Females during the Latter Half of the Joseon Dynasty as Reconstructed with Cases in Yeoksi Manpil (Stray Notes w





hwp

한국성인에서초기황반변성질환과 연관된위험요인연구

서론 34 2

431_439특집_문신용

A 617

Microsoft Word doc

원위부요척골관절질환에서의초음파 유도하스테로이드주사치료의효과 - 후향적 1 년경과관찰연구 - 연세대학교대학원 의학과 남상현

황지웅

012임수진

,,,,,,, ,, 2 3,,,,,,,,,,,,,,,, (2001) 2

전립선암발생률추정과관련요인분석 : The Korean Cancer Prevention Study-II (KCPS-II)

Rheu-suppl hwp

Can032.hwp

노영남

Microsoft Word - 02-황정혜.DOC

44-4대지.07이영희532~

°Ç°�°úÁúº´5-44È£ÃÖÁ¾

Microsoft Word - 9-전진현.DOC

IKC43_06.hwp

歯kjmh2004v13n1.PDF


사용시 기본적인 주의사항 경고 : 전기 기구를 사용할 때는 다음의 기본적인 주의 사항을 반드시 유의하여야 합니다..제품을 사용하기 전에 반드시 사용법을 정독하십시오. 2.물과 가까운 곳, 욕실이나 부엌 그리고 수영장 같은 곳에서 제품을 사용하지 마십시오. 3.이 제품은

Lumbar spine

step 1-1

0태아 초음파 검사-한글(10월25일).PDF

청소년 임신에 따른 임산부와 신생아의 주산기 문제점 한, 의학적으로 관심을 가져야 할 부분으로 1대 임신과 성병, 가족 계획 및 피임방법 등에 관련한 생식 건강도 포함된다 1). 청소년 임신은 태아의 자궁 내 성장 지연, 태 아 곤란, 자궁 내 사망 등의 위험을 증가시

ePapyrus PDF Document


<31342EBCBAC7FDBFB52E687770>

<BFACBCBCC0C7BBE7C7D E687770>

Abstract Background : Most hospitalized children will experience physical pain as well as psychological distress. Painful procedure can increase anxie

슬라이드 1


untitled

( )Jkstro011.hwp

석사논문.PDF

Microsoft Word - 07-이성구.DOC

<303038C0AFC8A3C1BE5B315D2DB1B3C1A42E687770>

11¹ÚÇý·É

16(1)-3(국문)(p.40-45).fm

<5B32335DB1E8C0B1BDC42DC0D3BDC5C3CAB1E2C0D3BDC5BEE7BBF32D3131BFF93234C0CFC1A2BCF62E687770>

590호(01-11)

Minimally invasive parathyroidectomy

<BFA9BAD02DB0A1BBF3B1A4B0ED28C0CCBCF6B9FC2920B3BBC1F62E706466>

<3034C0D3BBF3C3E1B0E8C7D0BCFABCBCB9CCB3AA2E687770>

제 4 장

퇴좈저널36호-4차-T.ps, page Preflight (2)

< DBFF8C0FA28B1E8C7FDBFC12DBEE7BDC2C7E D E696E6464>

현대패션의 로맨틱 이미지에 관한 연구

Microsoft Word - 05-이형송.DOC

김범수

,,,.,,,, (, 2013).,.,, (,, 2011). (, 2007;, 2008), (, 2005;,, 2007).,, (,, 2010;, 2010), (2012),,,.. (, 2011:,, 2012). (2007) 26%., (,,, 2011;, 2006;

< FB4EBB1B8BDC320BAB8B0C7BAB9C1F6C5EBB0E8BFACBAB820B9DFB0A320BFACB1B85FBEF6B1E2BAB92E687770>

ÀÌÁÖÈñ.hwp

Treatment and Role of Hormaonal Replaement Therapy

Analyses the Contents of Points per a Game and the Difference among Weight Categories after the Revision of Greco-Roman Style Wrestling Rules Han-bong


대한한의학원전학회지26권4호-교정본(1125).hwp

Journal of Educational Innovation Research 2019, Vol. 29, No. 1, pp DOI: : * Research Subject

<32B1B3BDC32E687770>

Journal of Educational Innovation Research 2017, Vol. 27, No. 2, pp DOI: : Researc

시행 사증발급신청서, 외국인배우자초청장.hwp

한국 출산력의 저하 요인에 관한 연구

보건사회연구-25일수정

歯1.PDF

Microsoft Word - 06-박찬우.DOC

Microsoft PowerPoint Hot_topics___future_landscapes_20 August 14_FINAL_Korean

04_이근원_21~27.hwp

<31342D3034C0E5C7FDBFB52E687770>

ftp_ xls

Microsoft Word - 3-서창석.DOC


untitled

ePapyrus PDF Document

09È«¼®¿µ 5~152s

<31372DB9CCB7A1C1F6C7E22E687770>

,......

2 / 26

Kor. J. Aesthet. Cosmetol., 및 자아존중감과 스트레스와도 밀접한 관계가 있고, 만족 정도 에 따라 전반적인 생활에도 영향을 미치므로 신체는 갈수록 개 인적, 사회적 차원에서 중요해지고 있다(안희진, 2010). 따라서 외모만족도는 개인의 신체는 타

untitled

서론

저작자표시 - 비영리 - 변경금지 2.0 대한민국 이용자는아래의조건을따르는경우에한하여자유롭게 이저작물을복제, 배포, 전송, 전시, 공연및방송할수있습니다. 다음과같은조건을따라야합니다 : 저작자표시. 귀하는원저작자를표시하여야합니다. 비영리. 귀하는이저작물을영리목적으로이용할

해당하는 논문이 있었다. 즉 이런 분류 방식이 중복출판 분류에 충분히 적용 가능함을 알 수 있었다. 또한 과거 분류한 것보다 조금 더 자세히 나누어서 어디에 해당하는지 쉽게 찾을 수 있는 방안이다. 사례를 보고 찾는다면 더욱 쉽게 해당하는 범주를 찾을 수 있을 것이다.

<B3EDB9AEC1FD5F3235C1FD2E687770>

레이아웃 1

( )Kjhps043.hwp

Transcription:

Korean Journal of Obstetrics and Gynecology Vol. 53 No. 12 December 2010 조사보고서한국보조생식술의현황 : 2007년 대한산부인과학회 보조생식술소위원회 Current status of assisted reproductive technology in Korea, 2007 Korean Society of Obstetrics and Gynecology Assisted reproductive technology (ART) committee 1986 년국내에서체외수정시술에의한첫시험관아기가탄생한이래불임환자치료를위한보조생식술은날로그시술기관과시행수가증가되고있을뿐만아니라, 치료성적도괄목할만큼개선되는등불임증진단과치료에많은발전이있어왔다. 불임을치료하기위해보조생식술을시행하고있는의료기관으로부터의자료는성공적인보조생식술, 즉생아 (live birth) 의출산을가능하게하는여러가지요소들에대한풍부하고귀중한자료가될수있다. 각의료기관별의치료성적은그자체로도의미가있지만성공률과성공에영향을주는요소에대한통합적인분석을위해서는국내의여러의료기관으로부터의자료를취합하여국내통계를구해보는것이의미가있을것이며, 이러한조사는국내불임환자및보조생식술시술기관의실태파악에도움을주는것은물론궁극적으로국내보조생식술에관한전체적이고일관성있는자료를장기적으로처리분석하여불임증치료의방향까지제시할수있을것으로기대된다. 1993 년 5월제정된인공수태윤리에관한선언에의하면, 인준된인공수태시술의료기관은그시술내용을연 1회 접수일 :2010. 7. 9. 채택일 :2010. 8. 6. 교신저자 : 최영민 E-mail:ymchoi@snu.ac.kr 이상대한의사협회 ( 또는동협회가지정한관련학회 ) 에보고하도록되어있으며, 1994 년본학회내에인공수태시술의료기관심사소위원회가설치되었다. 그리고 2005 년부터는 생명윤리및안전에관한법률 이시행되어모든배아생성의료기관은보건복지부의인준을받도록되어있으며, 2009 년 7월현재 155 개기관이인준되어있다. 대한산부인과학회에서는 1992 년부터국내보조생식술의현황을조사하여보고하여오고있으며, 이러한조사사업의일환으로 2007 년도보조생식술현황도조사하여이에보고하게되었다. 본조사에의해얻어진국내보조생식술에대한자료는불임환자및보조생식술시술기관의실태파악에도움을주는것은물론더나아가서는시술방법의계속적인개선과발전, 부작용의감소와임신성공률의향상을도모하는데유용한자료로활용될것이다. 본조사연구는대한산부인과학회의재정지원하에수행되었으며, 실무에서많은노력을기울인대한산부인과학회의직원여러분들과서울대학교병원의김재원, 박주희선생님, 자료정리에애써주신서울대학교병원전공의및전임의선생님들, 그리고본조사에협조하여주신국내각배아생성의료기관의여러분들께본위원회에서는깊은감사의말을전하고자한다. 2010년 8월 - 1052 -

최영민. 한국보조생식술의현황 : 2007 년 대한산부인과학회보조생식술소위원회위원장최영민 ( 서울의대 ) 간사이원돈 ( 마리아병원 ) 위원강인수 ( 관동의대 ) 권혁찬 ( 미래와희망산부인과 ) 김기철 ( 함춘여성의원 ) 김선행 ( 고려의대 ) 노성일 ( 미즈메디병원 ) 문신용 ( 서울의대 ) 문화숙 ( 문화병원 ) 민응기 ( 동국의대 ) 윤태기 ( 포천중문의대 ) 이규섭 ( 부산의대 ) 이상훈 ( 중앙의대 ) 이여일 ( 전남의대 ) 이정호 ( 계명의대 ) 전상식 ( 경북의대 ) 한혁동 ( 연세의대 ) 황경주 ( 아주의대 ) 황정혜 ( 한양의대 ) ( 이상가나다순 ) 대상및방법 1. 조사대상본연구의목적은 2007 년 1월 1일부터 2007 년 12월 31 일까지국내에서시술된보조생식술의현황및시술성적을파악하고자하는것이다. 조사시점인 2009 년 7월당시보건복지부에배아생성의료기관으로인준되어있는 140 개의의료기관을대상으로설문지를발송하였으며 (Fig. 1), 이들기관중시술성적을보고한 74개의의료기관중시술예가있는 74개기관의결과를종합하여분석하였다. 본연구조사결과분석에포함된의료기관은다음과같으며 1년간시행하는총치료주기의수에따라의료기관을분류해보면 Table 1과같다. 1. 가야자모병원, 진주 2. 강릉미즈산부인과의원, 강릉 Fig. 1. Location of certified ART (assisted reproductive technology) clinics in Korea, 2007. 3. 건양대학교병원, 대전 4. 경북대학교병원, 대구 5. 경상대학교병원, 진주 6. 계명대학교동산병원, 대구 7. 광주기독병원, 광주 8. 광주미래와희망산부인과의원, 광주 9. 동국대학교일산병원, 고양 10. 동국대학교경주병원, 경주 11. 동아대학교병원, 부산 12. 동원산부인과의원, 고양 13. 동탄제일산부인과, 화성 14. 마마파파 & 베이비산부인과의원, 울산 15. 메디아이여성병원, 서울 16. 미래여성병원, 대구 17. 미래여성병원, 대전 18. 미래와희망산부인과의원, 서울 19. 미즈메디병원 ( 강남 ), 서울 20. 미즈메디병원 ( 강서 ), 서울 21. 민병열산부인과의원, 청주 22. 부산대학교병원, 부산 23. 분당서울대학교병원, 성남 - 1053 -

대한산부회지제 53 권제 12 호, 2010 Table 1. Number of IVF centers according to size (total number of treatment in the year) Number of treatment started in the year of 2007 Number of IVF centers 1,000 or more 7 500~999 8 200~499 10 100~199 9 Less than 100 40 Number of IVF centers providing data for this report 74 Total number of IVF centers 140 IVF: in vitro fertilization. 24. 분당제일여성병원, 성남 25. 사회복지법인삼성병원공익재단삼성서울병원, 서울 26. 삼성미래산부인과, 부천 27. 삼성산부인과병원, 수원 28. 서울대학교병원, 서울 29. 서울여성병원, 인천 30. 시엘병원, 광주 31. 신여성병원, 의정부 32. 아름병원, 부산 33. 아주대학교병원, 34. 양정분산부인과의원, 이천 35. 에덴산부인과의원, 익산 36. 엘르메디산부인과의원, 창원 37. 연세대학교의과대학신촌세브란스병원, 서울 38. 연세대학교원주의과대학원주기독병원, 원주 39. 예일마리여성의원, 울산 40. 의료법인마리아의료재단마리아의원, 대구 41. 의료법인마리아의료재단마리아의원, 대전 42. 의료법인마리아의료재단마리아의원, 부산 43. 의료법인마리아의료재단마리아의원, 고양 44. 의료법인을지병원, 서울 45. 의료법인마리아의료재단신설동마리아병원, 서울 46. 의료법인명지의료재단명지병원, 고양 47. ( 의 ) 정우의료재단프라우메디병원, 울산 48. 이도근산부인과의원, 진주 49. 이화산부인과의원, 청주 50. 이화의대부속목동병원, 서울 51. 인정병원, 서울 52. 인하대학교의과대학부속병원, 인천 53. 재단법인아산사회복지재단서울아산병원, 서울 54. ( 재 ) 한 호기독교선교회일신기독병원, 부산 55. 전남대학교병원, 광주 56. 제일산부인과의원, 익산 57. 제일의료재단제일병원, 서울 58. 조선대학교병원, 광주 59. 좋은문화병원, 부산 60. 진산부인과의원, 전주 61. 차병원, 서울 62. 차산부인과의원, 제주 63. 포천중문의과대학분당차병원, 성남 64. 프레메디산부인과의원, 광주 65. 프리모산부인과의원, 청주 66. 학교법인고려중앙학원고려대학교의과대학부속병원, 서울 67. 학교법인고황재단경희의대부속병원, 서울 68. 학교법인을지대학병원, 대전 69. 학교법인인제대학부속부산백병원, 부산 70. 한나산부인과의원, 서울 71. 한빛여성병원, 서울 72. 한양대학교병원, 서울 73. 함춘여성의원, 서울 74. 허유재병원, 고양 ( 가나다순 ) 2. 조사방법조사설문지를대상기관에 e-mail 로발송하였으며, e-mail 로설문지를회수하였다. 발송된설문지는다음과같다. - 1054 -

최영민. 한국보조생식술의현황 : 2007 년 2007 년도보조생식술시술결과보고서 REGISTRATION FORM OF ASSISTED REPRODUCTION: 2007 PLEASE READ INSTRUCTIONS AND FOOTNOTES CAREFULLY BEFORE COMPLETING THE FORMS Name of IVF Center ( 한글 ) Name of IVF Center ( 영문 ) Contact Person Name ( 한글 ) Tel Fax E-mail Address ( 한글 ) World report 에각기관의영문명이첨부됩니다. 정확한영문기관이름을적어주십시오. All data relate to treatment that were started during the calendar year, 2007, and to any clinical resulting from those treatment. Please complete as many data items as possible (n = number). If data are not available for some items, write NA. Gestational age (duration of pregnancy) should be calculated by adding 14 days (2 weeks) to the number of completed weeks between the date of fertilization (conception) and the date of completion of the pregnancy. In the following tables : Standard IVF (IVF without ICSI) includes those treatment and in which fertilization occurred, or was intended to occur, in the laboratory and fresh embryos were transferred to the uterus or fallopian tubes. This heading excludes : (1) frozen/thawed embryo transfer ; and (2) microinsemination techniques. ICSI includes those treatment and that follow transfer of fresh embryos after intracytoplasmic sperm injection. after both ICSI and embryo freezing are recorded separately. GIFT includes only those and in which gametes (oocytes and sperm) were transferred to the fallopian tubes (excluding combined IVF and GIFT in the same cycle, which should be recorded in IVF category). 주의 : 본보고서에서 ART procedure를 1) Standard IVF (IVF without ICSI), 2) ICSI, 3) ZIFT 4) GIFT, 5) FET (Frozen Embryo ) after standard IVF, 6) FET after ICSI, 7) Oocyte donation의 7가지로구분하고있습니다. 그리고이항목들의대상은상호중첩되지않으니숫자기입시유의하시기바랍니다. If you did not perform ART practice in 2007, check here Not done If you performed ART practice in 2007, please fill out tables below. - 1055 -

대한산부회지제 53 권제 12 호, 2010 ART Report Forms, Korea 2007 Module Ia Pregnancy Outcomes in relation to Treatment Table 1a-1. Pregnancy outcomes : IVF, ICSI, ZIFT, GIFT IVF without ICSI IVF with ICSI ZIFT GIFT Initiated Cycles with oocyte retrieval attempted (aspiration) s 1 embryo (oocyte 1 ) 2 embryos (oocytes) 3 embryos (oocytes) 4 embryos (oocytes) 5 embryos (oocytes) 6 embryos (oocytes) All 2 (intrauterine) Pregnancy losses 3 Pregnancies with one or more live births follow-up 4 * This table excludes in which frozen/thawed embryos were transferred. ( 이테이블에는 frozen/thawed embryo 를사용한 cycle 은포함하지않습니다.) 1: in case of GIFT 2: pregnancy: Presence of an intrauterine gestational sac on ultrasound examination ( pregnancy 는초음파에서자궁내태낭을확인한경우로제한됩니다.) 3: pregnancy (intrauterine) 가확인되었으나임신 20 주이전 abortion 된경우 4: pregnancy (intrauterine) 가확인되었으나 Pregnancy outcome (abortion or delivery) 을확인하지못한임신의수 - 1056 -

최영민. 한국보조생식술의현황 : 2007 년 Table 1a-2. Pregnancy outcomes after transfer of frozen/thawed embryos FET 1 : embryos obtained after IVF without ICSI Thawing s 1 embryo 2 embryos 3 embryos 4 embryos 5 embryos 6 embryos All (intrauterine) Pregnancy losses 2 Pregnancies with one or more live births follow-up 3 FET: embryos obtained after IVF with ICSI 1 : FET (Frozen Embryos ) 2 : pregnancy (intrauterine) 가확인되었으나임신 20 주이전 abortion 된경우 3 : pregnancy (intrauterine) 가확인되었으나 Pregnancy outcome (abortion or delivery) 을확인하지못한임신의수 Table 1a-3. Pregnancy outcomes after oocyte donation Cycle Donation s 1 embryo 2 embryos 3 embryos 4 embryos 5 embryos 6 embryos All (intrauterine) Pregnancy losses 1 Pregnancies with one or more live births - 1057 -

대한산부회지제 53 권제 12 호, 2010 ART Report Forms, Korea 2007 Module Ib Complications of Treatment Table 1b. Complications that require admission to hospital Complications Hyperstimulation syndrome Complications of oocyte retrieval Bleeding Infection All Maternal deaths related to the ART process Maternal deaths related to the pregnancy itself *If a woman had two occurrences of the same complication, in 2 different, count her twice. *If a woman had two different complications, count her in each of them. - 1058 -

최영민. 한국보조생식술의현황 : 2007 년 ART Report Forms, Korea 2007 Module 2 Deliveries in relation to Treatment Table 2-1. Standard IVF (IVF without ICSI) Singleton deliveries Twin deliveries Triplet (or higher order) deliveries All deliveries * Deliveries, not babies. Percentage Table 2-2. ICSI (IVF with ICSI) Singleton deliveries Twin deliveries Triplet (or higher order) deliveries All deliveries * Deliveries, not babies. Percentage Table 2-3. Frozen Embryo Singleton deliveries Twin deliveries Triplet (or higher order) deliveries All deliveries * Deliveries, not babies. Percentage Table 2-4. Oocyte Donation Singleton deliveries Twin deliveries Triplet (or higher order) deliveries All deliveries * Deliveries, not babies. Percentage Table 2-5. Induced Abortions (not SFR) Standard IVF ICSI Percentage/All Pregnancies Table 2-6. Induced Reductions (SFR) Standard IVF ICSI Percentage/All Pregnancies - 1059 -

대한산부회지제 53 권제 12 호, 2010 ART Report Forms, Korea 2007 Module 3a Perinatal Mortality in relation to Treatment and Multiple Deliveries Table 3a-1. Fresh (total aspiration following IVF and/or ICSI) (Not Deliveries, but Baby No.) Health status in the perinatal period Pregnancy order Number of neonates Total Stillbirths Live births Neonatal deaths Unknown Singleton Twin Triplet Quadruplet or higher Unknown Total This table excludes PGD and OD This table reports number of neonates (2 for twins, 3 for triplets,..). Table 3a-2. FET (total transfer following IVF and/or ICSI) (Not Deliveries, but Baby No.) Health status in the perinatal period Pregnancy order Number of neonates Total Stillbirths Live births Neonatal deaths Unknown Singleton Twin Triplet Quadruplet or higher Unknown Total This table excludes PGD and OD This table reports number of neonates (2 for twins, 3 for triplets,..). Table 3a-3. Oocyte donation (total transfer following IVF and/or ICSI) (Not Deliveries, but Baby No.) Health status in the perinatal period Pregnancy order Number of neonates Total Stillbirths Live births Neonatal deaths Unknown Singleton Twin Triplet Quadruplet or higher Unknown Total This table excludes PGD This table reports number of neonates (2 for twins, 3 for triplets,..). - Live births : 20 weeks - Stillbirths : 20 weeks - Neonatal deaths are all the deaths occurring after birth, up to 7 completed days of life. - Stillborn include deaths occurring during the delivery process. - 1060 -

최영민. 한국보조생식술의현황 : 2007 년 ART Report Forms, Korea 2007 Module 3b Malformations in relation to Treatment (includes chromosomal abnormalities) Table 3b-1. Standard IVF (IVF without ICSI) number of neonates/fetuses with congenital anomalies* Technique Abortion Total Delivered** Spontaneous Induced Total IVF fresh cycle ICSI fresh cycle FET (IVF and/or ICSI) Oocyte donation PGD GIFT TOTAL *: malformations and genetic abnormalities **: including stillbirths and those with unknown health status at birth Delivery 20 weeks, abortion <20 weeks Table 3b-2. ICSI (IVF with ICSI) Technique IVF fresh cycle ICSI fresh cycle FET (IVF and/or ICSI) Oocyte donation PGD GIFT TOTAL Total number of neonates/fetuses with congenital anomalies* Delivered** *: malformations and genetic abnormalities **: including stillbirths and those with unknown health status at birth Delivery 20 weeks, abortion <20 weeks Fetal losses Spontaneous Induced Total - 1061 -

대한산부회지제 53 권제 12 호, 2010 Table 3b-3. FET (Frozen Embryo with/without ICSI) number of neonates/fetuses with congenital anomalies* Technique Fetal losses Total Delivered** Spontaneous Induced Total IVF fresh cycle ICSI fresh cycle FET (IVF and/or ICSI) Oocyte donation PGD GIFT TOTAL *: malformations and genetic abnormalities **: including stillbirths and those with unknown health status at birth Delivery 20 weeks, abortion <20 weeks Table 3b-4. Oocyte Donation number of neonates/fetuses with congenital anomalies* Technique Fetal losses Total Delivered** Spontaneous Induced Total IVF fresh cycle ICSI fresh cycle FET (IVF and/or ICSI) Oocyte donation PGD GIFT TOTAL *: malformations and genetic abnormalities **: including stillbirths and those with unknown health status at birth Delivery 20 weeks, abortion <20 weeks - 1062 -

최영민. 한국보조생식술의현황 : 2007 년 Please list malformations which were reported, if available: Table 3c. List of congenital anomalies (Malformations and genetic abnormalities) Baby Congenital anomalies (Describe all anomalies found in each baby) Woman s Age * Technique * ART Semen/ sperm * Gestational age at birth/ abortion * Status * 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. - 1063 -

대한산부회지제 53 권제 12 호, 2010 ART Report Forms, Korea 2007 Module 4 Outcomes by Maternal Age, Cause of Infertility Table 4-1. Number of oocyte retrieval and clinical by maternal age, 2007 Standard IVF (IVF without ICSI) Women s age at start of treatment <25 yrs 25-29 30-34 35-39 40 Initiated Cycles with oocyte retrieval attempted Pregnancy losses 1 Pregnancies with one or more live births Women s age at start of treatment <25 yrs 25-29 30-34 35-39 40 Initiated Cycles with oocyte retrieval attempted IVF with ICSI Pregnancy losses 1 Pregnancies with one or more live births Women s age at start of treatment <25 yrs 25-29 30-34 35-39 40 Thawing Cycles with embryo transfer Frozen embryo transfers after IVF without ICSI Pregnancy losses 1 Pregnancies with one or more live births - 1064 -

최영민. 한국보조생식술의현황 : 2007 년 Women s age at start of treatment <25 yrs 25-29 30-34 35-39 40 Thawing Cycles with embryo transfer Frozen embryo transfers after IVF with ICSI Pregnancy losses 1 Pregnancies with one or more live births Women s age at start of treatment <25 yrs 25-29 30-34 35-39 40 Initiated Cycles with oocyte retrieval attempted ZIFT Pregnancy losses 1 Pregnancies with one or more live births Women s age at start of treatment <25 yrs 25-29 30-34 35-39 40 Initiated Cycles with oocyte retrieval attempted GIFT Pregnancy losses 1 Pregnancies with one or more live births Women s age at start of treatment <25 yrs 25-29 30-34 35-39 40 Initiated Cycles with oocyte retrieval attempted Oocyte Donation Pregnancy losses 1 Pregnancies with one or more live births - 1065 -

대한산부회지제 53 권제 12 호, 2010 Table 4-2. Number of oocyte retrieval and clinical by cause (s) of infertility, 2007 Standard IVF (IVF without ICSI) Cause (s) of infertility Initiated Cycles with oocyte retrieval attempted Pregnancy losses 1 Pregnancies with one or more live births Female only Male factor only Mixed male and female Unexplained Other factors -The groups in the sections on cause of infertility are mutually exclusive so each treatment cycle or pregnancy should be included in only one group. 1 : pregnancy (intrauterine) 가확인되었으나임신 20주이전 abortion된경우 Cause (s) of infertility Initiated Cycles with oocyte retrieval attempted IVF with ICSI Pregnancy losses 1 Pregnancies with one or more live births Female only Male factor only Mixed male and female Unexplained Other factors -The groups in the sections on cause of infertility are mutually exclusive so each treatment cycle or pregnancy should be included in only one group. 1 : pregnancy (intrauterine) 가확인되었으나임신 20주이전 abortion된경우 Cause (s) of infertility Female only Male factor only Mixed male and female Unexplained Other factors Initiated Cycles with oocyte retrieval attempted ZIFT Pregnancy losses 1 Pregnancies with one or more live births -The groups in the sections on cause of infertility are mutually exclusive so each treatment cycle or pregnancy should be included in only one group. - 1066 -

최영민. 한국보조생식술의현황 : 2007 년 GIFT Cause (s) of infertility Initiated Cycles with oocyte retrieval attempted Pregnancy losses 1 Pregnancies with one or more live births Female only Male factor only Mixed male and female Unexplained Other factors -The groups in the sections on cause of infertility are mutually exclusive so each treatment cycle or pregnancy should be included in only one group. Frozen embryo transfers after IVF without ICSI Cause (s) of infertility Thawing Cycles with oocyte retrieval attempted Pregnancy losses 1 Pregnancies with one or more live births Female only Male factor only Mixed male and female Unexplained Other factors -The groups in the sections on cause of infertility are mutually exclusive so each treatment cycle or pregnancy should be included in only one group. Frozen embryo transfers after ICSI Cause (s) of infertility Thawing Cycles with oocyte retrieval attempted Pregnancy losses 1 Pregnancies with one or more live births Female only Male factor only Mixed male and female Unexplained Other factors -The groups in the sections on cause of infertility are mutually exclusive so each treatment cycle or pregnancy should be included in only one group. - 1067 -

대한산부회지제 53 권제 12 호, 2010 Table 4-3. Number of oocyte retrieval and clinical by number of embryos or oocytes transferred, 2007 Standard IVF Number of embryos transferred Pregnancy losses 1 Pregnancies with one or more live births Singleton Twin Triplet or more One Two Three Four Five Six or more 1 : pregnancy (intrauterine) 가확인되었으나임신 20주이전 abortion된경우 Number of embryos transferred Pregnancy losses 1 Pregnancies with one or more live births IVF with ICSI Singleton Twin Triplet or more One Two Three Four Five Six or more 1 : pregnancy (intrauterine) 가확인되었으나임신 20주이전 abortion된경우 Number of embryos transferred One Two Three Four Five Six or more Frozen embryo transfers after IVF without ICSI Pregnancy losses 1 Pregnancies with one or more live births Singleton Twin Triplet or more - 1068 -

최영민. 한국보조생식술의현황 : 2007 년 Number of embryos transferred Pregnancy losses 1 Frozen embryo transfers after ICSI Pregnancies with one or more live births Singleton Twin Triplet or more One Two Three Four Five Six or more 1 : pregnancy (intrauterine) 가확인되었으나임신 20주이전 abortion된경우 Number of embryos transferred Pregnancy losses 1 Pregnancies with one or more live births ZIFT Singleton Twin Triplet or more One Two Three Four Five Six or more 1 : pregnancy (intrauterine) 가확인되었으나임신 20주이전 abortion된경우 Number of oocytes transferred One Two Three Four Five Six or more Pregnancy losses 1 Pregnancies with one or more live births GIFT Singleton Twin Triplet or more - 1069 -

대한산부회지제 53 권제 12 호, 2010 ART Report Forms, Korea 2007 Module 5 Embryo Freezing and Other Special Techniques Table 5-1. Embryo freezing, 2007 Have you ever performed embryo freezing in 2007? Yes ( ), No ( ) Number of oocyte pick-up (OPU) that resulted in embryo freezing in 2007 Number of embryos that were frozen in 2007 Total number of embryos in frozen storage at present Table 5-2. Oocyte retrieval, transfer and using special techniques of sperm collection and/or assisted hatching, 2007 Selected techniques Oocyte retrieval attempted Pregnancy losses 1 Pregnancies with one or more live births Microepididymal sperm aspiration (MESA) Testicular sperm extraction (TESE) Other and unspecified techniques of sperm collection* Assisted hatching 1 : pregnancy (intrauterine) 가확인되었으나임신 20주이전 abortion된경우 *: describe: * 이상입니다. 기입하여주셔서감사드립니다. 작성시의문점이있으신경우나수정또는개선점이있으시면서울의대산부인과최영민교수 ( 전화 : 02-2072-2385, HP: 010-3248-2385, Fax: 02-762-3599, E-mail: ymchoi@snu.ac.kr) 에게연락하여주십시오. - 1070 -

최영민. 한국보조생식술의현황 : 2007 년 본조사에서는체외수정및자궁내배아이식술 (in vitro fertilization-embryo transfer, IVF-ET) 중난자세포질내정자주입술 (intracytoplasmic sperm injection, ICSI) 을시행한경우를분리하여조사하였으며마찬가지로냉동보존배아를이용한 IVF-ET 의경우에도 ICSI 를시행한군과시행하지않은군으로나누어조사하였다. 모든자료들은 2007 년에시작된치료주기에관련된것이고따라서 2007 년에시작된주기의결과로발생한임상적임신은모두분석에포함하였다. 임상적임신은초음파에의한태낭의확인또는소파술로얻어진임신산물등의임신의임상적증후가있는경우만을포함하고단순히혈중 β-hcg 만의상승이있었던생화학적임신은제외하였다. 임신주수는수정으로부터임신이종결된시점간의기간에 14일 (2주 ) 을더하여 completed weeks 의수로나타내었다. 그리고취합된자료들은 Microsoft 사의 Excel 프로그램과 Window 용 SPSS ver. 12 (SPSS Inc., Chicago, IL, USA) 프로그램을이용하여분석하였다. 결과분석및고찰 1. 2007 년도한국보조생식술시술개요 2007 년의시술예를보고해온국내의 74개의보조생식술시술기관에서총 27,150 예의보조생식술을시행하였다 (Table 2). 2000 년에는 58개의시술기관에서 15,619 예, 2001년에는 53개의시술기관에서총 14,667예, 2002년에는 69개시술기관에서 18,310 예, 2003 년에는 48개시술기관에서 14,667 예, 그리고 2004 년에는 65개시술기관에서 17,802 예, 2005 년에는 76개시술기관에서 19,149 예, 2006 년에는 81개시술기관에서 29,733 예를보고한바있다. 1 보조생식술의시술방법별분포를보면, 총 27,150 예의주기중 IVF (ICSI 를병행한경우는제외 ) 9,634 예 (35.4%), ICSI 12,389예 (45.6%) 로 IVF와 ICSI 시술의합이총 22,023 예 (81.1%) 로대부분의보조생식술이신선배아를이용하는것으로이루어지고있음을알수있다. 냉동보존배아이식 (frozen embryo replacement, FER) 은 4,906예 (18.0%) 가시행되었으며, 난자공여시술 (oocyte donation) 은 215 예 (0.7%), 생식세포난관내이식술 (gamete intrafallopian transfer, GIFT) 은 0예, 접합자난관내이식술 (zygote intrafallopian transfer, ZIFT) 은 6예 (0.02%) 였다 (Table 2, Fig. 2). Table 2. pregnancy in relation to treatment Treatment / IVF ICSI ZIFT GIFT FER after FER after Oocyte IVF ICSI donation Cycles initiated (started) * 9,634 12,389 6 0 2,294 2,612 Cycles with oocyte retrieval 9,081 11,984 6 0 215 Cycles with embryo transfer 8,492 11,264 6 0 2,238 2,532 205 1 embryo (oocyte ) 383 1,395 1 0 190 221 9 2 embryo (oocytes) 1,103 1,738 0 0 505 554 23 3 embryo (oocytes) 2,663 2,775 1 0 747 862 61 4 embryo (oocytes) 2,523 2,892 1 0 464 555 57 5 embryo (oocytes) 1,552 1,976 0 0 220 246 51 6 embryo (oocytes) 268 488 3 0 112 94 4 3,202 3,410 0 0 694 735 82 (CP per retrieval, %) 35.3 28.5 0 0 (CP per transfer, %) 37.7 30.3 0 0 31.0 29.0 40.0 Live births * 2,633 2,699 0 0 548 590 74 (Live births per retrieval, %) 29.0 22.5 0 0 (Live births per transfer, %) 31.0 24.0 0 0 24.5 23.3 36.1 IVF: in vitro fertilization, ICSI: intracytoplasmic sperm injection, ZIFT: zygote intrafallopian transfer, GIFT: gamete intrafallopian transfer, FER: frozen embryos replacement, CP: clinical pregnancy. * estimated, in case of GIFT. - 1071 -

대한산부회지제 53 권제 12 호, 2010 2. IVF 와 ICSI 1) 임상적임신율및생아출생률 IVF 와 ICSI 를시행받은대상환자중총 6,612 명 ( 난자채취주기당 31.3%, 배아이식주기당 33.4%) 이임상적으로임신을확인할수있었으며, 추정하여 5,332 명 ( 난자채취주기당 25.3%, 배아이식주기당 26.9%) 이생아를출산하였다 (Table 2). 0.02% 18.0% 45.6% 0.7% 35.4% IVF-ET ICSI GIFT, ZIFT FER OD Fig. 2. Types of assisted reproductive technology procedures. IVF-ET: in vitro fertilization and embryo transfer, ICSI: intracytoplasmic sperm injection, GIFT: gamete intrafallopian transfer, ZIFT: zygote intrafallopian transfer, FER: frozen embryos replacement, OD: oocyte donation. 2) 대상환자의연령분포및이에따른임신율 IVF 와 ICSI 를시행받은대상환자의연령분포를보면 25세미만이 0.7%, 25~29 세가 11.4%, 30~34 세가 42.8%, 35~39 세가 31.6%, 40세이상이 13.5% 로 30~39 세가전체의 74.4% 로대부분을차지하였다 (Table 3-1, Fig. 3). 난자채취주기당임상적임신율은 25세미만이 45.2%, 25~29 세가 39.9%, 30~34세가 38.4%, 35~39세가 30.2%, 40세이상은 12.2% 로연령별로유의한차이가있었다 (P <0.001) (Table 3-1, Fig. 4). 3) 불임원인및이에따른임신율 IVF 와 ICSI 를시행받은대상환자의적응증, 즉불임증의원인인자별분포는여성인자 (female only) 만있는경우가 42.6%, 남성인자 (male factors only) 만있는경우가 18.5%, 여성인자와남성인자가공존하는경우 (mixed male and female) 가 11.8%, 원인불명의불임증 (unexplained) 이 24.0%, 기타다른인자가 3.2% 였다 (Table 4, Fig. 5). 난자채취주기당임상적임신율은여성인자만있는경우는 30.5%, 남성인자만있는경우는 36.8%, 여성인자와남성인자가공존하는경우는 27.5%, 원인불명의불임증은 35.8%, 기타다른인자의경우 21.8% 로원인별로유 Table 3-1. Number of oocyte retrieval and clinical by maternal age Maternal age at start of treatment <25 25~29 30~34 35~39 40 IVF ICSI Total OR CP (%) OR CP (%) OR CP (%) 71 1,068 3,964 2,703 926 31 (43.7) 466 (43.6) 1,624 (41.0) 899 (33.3) 159 (17.2) 75 1,240 4,684 3,678 1,797 35 (46.7) 456 (36.8) 1,695 (36.2) 1,027 (27.9) 172 (9.6) 146 2,308 8,648 6,381 2,723 66 (45.2) 922 (39.9) 3,319 (38.4) 1,926 (30.2) 331 (12.2) Total 8,732 3,179 (36.4) 11,474 3,385 (29.5) 20,206 6,564 (32.5) IVF: in vitro fertilization, ICSI: intracytoplasmic sperm injection, OR: oocyte retrieval, CP: clinical pregnancy. Table 3-2. Number of frozen embryo replacement and clinical by maternal age Maternal age at start of treatment <25 25~29 30~34 35~39 40 FER without ICSI FER with ICSI Total CP (%) CP (%) CP (%) 29 343 1,073 658 132 12 (41.4) 125 (36.4) 355 (33.1) 176 (26.7) 25 (18.9) 17 311 1,216 815 173 5 (29.4) 107 (34.4) 365 (30.0) 228 (28.0) 30 (17.3) 46 654 2,289 1,473 305 17 (37.0) 232 (35.5) 720 (31.5) 404 (27.4) 55 (18.0) Total 2,235 693 (31.0) 2,532 735 (29.0) 4,767 1,428 (30.0) FER: frozen embryos replacement, ICSI: intracytoplasmic sperm injection, CP: clinical pregnancy. - 1072 -

최영민. 한국보조생식술의현황 : 2007 년 Percentage (%) 50 45 40 35 30 25 20 15 10 5 0 0.7 11.4 36.0 31.6 <25 25-29 30-34 35-39 >40 Age (yr) 13.5 Fig. 3. Percentage of assisted reproductive technology users by ages: in vitro fertilization and intracytoplasmic sperm injection. CP/Retrieval (%) 50 45 40 35 30 25 20 15 10 5 0 45.2 39.9 36.0 30.2 <25 25-29 30-34 35-39 >40 Age (yr) 12.2 Fig. 4. pregnancy rates by ages of women, in vitro fertilization and intracytoplasmic sperm injection. CP: clinical pregnancy. 3.2% 24.0% 42.6% Female only Male only Mixed Other factor Unexplained Mixed 21.8 27.5 35.8 11.8% Unexplained Male only Other factors Female only 30.5 36.8 18.5% Fig. 5. Primary diagnosis for assisted reproductive technology procedures, in vitro fertilization and intracytoplasmic sperm injection. 0 10 20 30 40 Fig. 6. pregnancy rates by cause of infertility, in vitro fertilization and intracytoplasmic sperm injection. Table 4. Number of oocyte retrieval by cause of infertility Cause of infertility Female only Male factor only Mixed male and female Unexplained Other factors IVF ICSI Total OR CP (%) OR CP (%) OR CP (%) 4,504 488 589 2,731 210 1,602 (35.6) 189 (38.7) 190 (32.3) 1,074 (39.3) 49 (23.3) 4,091 3,236 1,786 2,102 428 1,020 (24.9) 1,180 (36.5) 462 (25.9) 655 (31.2) 90 (21.0) 8,595 3,724 2,375 4,833 638 2,622 (30.5) 1,369 (36.8) 652 (27.5) 1,729 (21.8) 139 (21.8) Total 8,522 3,104 (36.4) 11,643 3,407 (29.3) 20,165 6,511 (32.3) IVF: in vitro fertilization, ICSI: intracytoplasmic sperm injection, OR: oocyte retrieval, CP: clinical pregnancy. 의하게차이가있었다 (P <0.001) (Table 4, Fig. 6). 4) 이식배아수및이에따른임신율 IVF 와 ICSI 시행주기에서이식한배아의수는 1개의경우가 9.1%, 2개인경우 14.3%, 3개인경우 27.5%, 4개인경우 27.5%, 5개인경우 18.0%, 6개이상인경우 3.6% 였다 (Table 5-1). 이식주기당임상적임신율은 1개의경우가 10.2%, 2개인경우 25.7%, 3개인경우 38.8%, 4개인경우 39.2%, 5 개인경우 37.4%, 6개이상인경우 30.7% 로배아이식수에따라유의하게다른임신율을보였다 (P<0.001) (Table 5-1). - 1073 -

대한산부회지제 53 권제 12 호, 2010 Table 5-1. by number of embryos transferred Number of embryos transferred Standard IVF IVF with ICSI Total (%) (%) (%) One 390 48 (12.3) 1,393 133 (9.5) 1,783 181 (10.2) Two 1,094 329 (30.1) 1,720 393 (22.8) 2,814 722 (25.7) Three 2,664 1,109 (41.6) 2,755 994 (36.1) 5,419 2,103 (38.8) Four 2,511 1,007 (40.1) 2,892 1,112 (38.5) 5,403 2,119 (39.2) Five 1,562 589 (37.7) 1,982 737 (37.2) 3,544 1,326 (37.4) Six or more 253 84 (33.2) 456 134 (29.4) 709 218 (30.7) Total 8,474 3,166 (37.4) 11,198 3,503 (31.3%) 19,672 6,669 (33.9) IVF: in vitro fertilization, ICSI: intracytoplasmic sperm injection. Table 5-2. by number of frozen embryos transferred Number of embryos transferred Standard IVF IVF with ICSI Total (%) (%) (%) One 190 34 (19.9) 221 44 (19.9) 411 78 (19.0) Two 500 128 (25.6) 541 152 (28.1) 1,041 280 (26.9) Three 746 267 (35.8) 859 295 (34.3) 1,605 562 (35.0) Four 466 163 (35.0) 550 135 (24.5) 1,016 298 (29.3) Five 219 68 (31.1) 245 97 (39.6) 464 165 (35.6) Six or more 114 32 (28.1) 94 35 (37.2) 208 67 (32.2) Total 2,235 692 (31.0) 2,510 758 (30.2) 4,745 1,450 (30.6) IVF: in vitro fertilization, ICSI: intracytoplasmic sperm injection. Table 6. Deliveries in relation to treatment Singleton Twin deliveries Triplet deliveries All deliveries n (%) n (%) n (%) n (%) IVF 568 (65.6) 293 (33.8) 5 (0.6) 866 ICSI 870 (67.8) 411 (32.0) 3 (0.2) 1,284 FER 292 (70.2) 123 (29.6) 1 (0.2) 416 Oocyte donation 13 (56.5) 10 (43.5) 0 (0.0) 23 IVF: in vitro fertilization, ICSI: intracytoplasmic sperm injection, FER: frozen embryos replacement. 5) 다태아출생비율 IVF 와 ICSI 시행주기에서출생한총생아중단태아의비율은 49.9% 였으며쌍태아는 47.2%, 삼태아는 0.7% 였으 며사태아이상은없었다. 전체적으로쌍태아이상의다태임신의빈도가일반인구에서의쌍태아빈도가 3% 인것과 2 비교하면매우높은빈도이다 (Table 6, Fig. 7). - 1074 -

최영민. 한국보조생식술의현황 : 2007 년 Table 7. Oocyte retrieval, transfer and using special techniques of sperm collection and/or assisted hatching Selected techniques Oocyte retrieval attempted (% * ) Pregnancies with live births (% * ) MESA 54 52 17 (31.5) 3 (5.6) TESE 745 694 234 (31.4) 179 (24.0) Other and unspecified techniques of sperm collection * 53 49 17 (32.1) 7 (13.2) Assisted hatching 3,884 3,879 1,120 (28.8) 860 (22.1) MESA: microsurgical epididymal sperm aspiration, TESE: testicular sperm extraction. * per oocyte retrieval cycle. 47.2% 0.7% 49.9% Singleton Twin Triplet Fig. 7. Pluralities among live births: in vitro fertilization and intracytoplasmic sperm injection. 3. 난자공여시술 (Oocyte donation) 총 215 예의난자공여시술이있었으며, 205 예에서배아이식을시행하였다. 배아이식당임상적임신율은 40.0%, 생아출산율은 36.1% 였다 (Table 2). 4. 생식세포난관내이식술및접합자난관내이식술 생식세포난관내이식술은한예도없었다 (Table 2). 이는 2001 년의총 63예에서생식세포난관내이식술을시행한것에비하면많이감소한수치로 2005 년과 2006 년에는각각 1예시행하였다. 1 접합자난관내이식술 (ZIFT) 은총 6예가시행되었으며임신된예는없었다 (Table 2). 5. 냉동보존배아이식 (Frozen embryo replacement) 2007년에총 4,906 예의냉동보존배아이식시도가있었으며, 이중총 4,770 예에서냉동보존배아이식을시행하였다. 배아이식주기당임상적임신율은 30.0% 생아출산율은 23.9% 였다 (Table 2). 2006 년에는총 4,310 예의냉 동보존배아이식시도가있었으며, 이중총 3,051 예에서냉동보존배아이식을시행하여배아이식주기당임상적임신율은 33.5%, 생아출산율은 27.1% 를보였다. 2007 년도의배아이식주기당임상적임신율및생아출산율은 2006 년도와통계적으로유의한차이가없었다 (P=0.395, P=0.746). 2006 년도의배아이식주기당임상적임신율및생아출산율은 2005 년도 (32.9% 및 28.3%) 와유의한차이가없었음을보고한바있다 (P=0.633, P=0.289). 1 냉동보존배아이식시도를시행한환자의연령분포를보면 25세미만이 1.0%, 25~29 세가 13.7%, 30~34 세가 48.0%, 35~39 세가 30.9%, 40세이상이 6.4% 로 30~39 세가전체의 78.9% 로대부분을차지하였다 (Table 3-2). 이식주기당임상적임신율은 25 세미만이 37.0%, 25~29 세가 35.5%, 30~34 세가 31.5%, 35~39세가 27.4%, 40세이상은 18.0% 로연령별로유의한차이가있었다 (P <0.001) (Table 3-2). 이식한배아의수는 1개의경우가 8.7%, 2개인경우 21.9%, 3개인경우 33.8%, 4개인경우 21.4%, 5개인경우 9.8%, 6개이상인경우 4.4% 였다 (Table 5-2). 이식주기당임상적임신율은이식한배아의수가 1개의경우는 19.0%, 2개인경우 26.9%, 3개인경우 35.0%, 4개인경우 29.3%, 5개인경우 35.6%, 6개이상인경우 32.2% 로배아이식수에따라유의하게다른임신율을보였다 (P <0.001) (Table 5-2). 6. 수술적방법에의한정자채취와보조부화술 2007 년도에시행된 microsurgical epididymal sperm aspiration (MESA) 는총 54예이고난자채취주기당임신율은 31.5%, 난자채취주기당생아출생률은 5.6% 였다. Testicular sperm extraction (TESE) 는 745예에서시행 - 1075 -

대한산부회지제 53 권제 12 호, 2010 Table 8. Comparison with data from international registers Korea, 2007 US, 2007 3 ESHRE, 2005 4 IVF Cycles with oocyte retrieval 9,634 90,295 * 108,769 Cycles with embryo transfer 8,492 82,347 * 96,729 CP 3,202 36,079 * 29,302 CP per retrieval (%) 35.3 40.0 * 26.9 CP per transfer (%) 37.9 43.8 * 30.3 Live birth per retrieval (%) 29.0 32.7 * ICSI Cycles with oocyte retrieval 11,984 194,156 Cycles with embryo transfer 11,264 179,012 CP 3,410 55,305 CP per retrieval (%) 28.5 28.5 CP per transfer (%) 30.3 30.9 Live birth per retrieval (%) 22.5 FER after IVF with/without ICSI Cycles with embryo transfer 4,770 23,133 70,151 CP 1,429 8,111 13,719 CP per transfer 29.1 35.1 19.6 Live birth per transfer 23.9 27.5 US: United States, ESHRE: European Society for Human Reproduction and Embryology, IVF: in vitro fertilization, CP: clinical pregnancy, FER: frozen embryos replacement, ICSI: intracytoplasmic sperm injection. * including ICSI. 되었고난자채취주기당임신율은 31.4% 였고난자채취주기당생아출생률은 24.0% 였다. 보조부화술은 3,884 예에서시행되었고난자채취주기당임신율은 28.8%, 난자채취주기당생아출생률은 22.1% 였다 (Table 7). 7. 외국보고서와의비교보고된 2007 년도결과를국제데이터와비교한것은 Table 8과같다. 미국의경우 Centers for Disease Control and Prevention (CDC) 에서보고한 2007년 ART success rates: National summary and fertility clinic report 3 가최근보고이며, European Society for Human Reproduction and Embryology (ESHRE) 의최근보고인 2005 년보조생식술결과는 4 유럽 30개국의데이터를분석한것이다. ICSI 를포함한신선배아를이용한주기를비교할때, 미국의경우배아이식주기당임상적임신율이 43.8% 로우리나라의 33.4% 에비해유의하게높았으며 (P <0.001), ESHRE 보고의경우배아이식주기당임상적임신율은 30.7% 이었다 (Table 8). 냉동보존배아이식의경우에서는미국의경우배아이식주기당임상적임신율이 35.1% 로 우리나라의 33.5% 에비해통계적으로유의하게높았다 (P <0.001). 반면, 우리나라와유럽의결과를비교할때 ESHRE 에서보고한유럽의냉동보존배아이식의경우배아이식주기당임상적임신율이 19.6% 로우리나라의결과에비해통계적으로유의하게낮았다 (P <0.001) (Table 8). 맺음말 2007 년도한국의보조생식술현황은기존의 2006 년까지의보고 1 와큰차이는없었다. 국외의경우신선배아를이용한경우에비해냉동배아를이용한경우임신율이떨어진것처럼, 우리나라의경우에도냉동배아를이용한경우의임상적임신율이신선배아를이용한임신율보다통계적으로유의하게떨어져있었다 (P <0.001) (Table 2). 2005 년보조생식술현황보고에서는냉동배아를이용한경우의임상적임신율이신선배아를이용한경우보다통계적으로유의하게높았음을보고한바있다 (P <0.001). 1 보조생식술의성공에영향을줄수있는중요한요인으로여성의나이, 배아이식수등이포함되는점은이전결과들과같았다. - 1076 -

최영민. 한국보조생식술의현황 : 2007 년 1. ART committee, Korean Society of Obstetrics and Gynecology. Current status of assisted reproductive technology in Korea, 2006. Korean J Obstet Gynecol. 2009; 52: 1212-38. 2. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gillstrap LC III, Wenstrom KD. Williams Obstetrics. 22nd ed. New York: McGraw-Hill; 2005. 참고문헌 3. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2007 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports, Atlanta (US): Department of Health and Human Services, Centers for Disease Control and Prevention; 2009. 4. Nyboe Andersen A, Goossens V, Bhattacharya S, Ferraretti AP, Kupka MS, de Mouzon J, et al. Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE: ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod 2009; 24: 1267-87. - 1077 -